sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 526-550 out of 1333.

<< < 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 > >>

Public Release: 2-Aug-2016
Lancet Global Health
Rapid bacterial infection test reduces antibiotic use
A trial of a 5-minute test at ten primary care centres in Vietnam reduced antibiotic use for respiratory infections. The rapid test detects C-reactive protein (CRP), a marker of infections caused by bacteria, in patients' blood: low CRP is suggestive of viral infection where antibiotic treatment is not required.
Wellcome Trust, Global Antibiotic Resistance Partnership,Center for Disease Dynamics, Economics & Policy, Bill & Melinda Gates Foundation

Contact: Katrina Lawson
klawson@oucru.org
84-166-876-7900
University of Oxford

Public Release: 2-Aug-2016
Journal of The Royal Society Interface
Research targets number one killer of under-5s
Oxford researchers are developing a tool to make it much easier and cheaper to diagnose pneumonia -- the number one killer of children under 5. Currently, diagnosis requires X-ray and microbiology lab facilities -- unavailable in many areas of the world.
Engineering and Physical Sciences Research Council, Research Councils UK Digital Economy Programme,Wellcome Trust

Contact: Tom Calver
news.office@admin.ox.ac.uk
44-186-527-0046
University of Oxford

Public Release: 2-Aug-2016
PLOS Medicine
Collateral harm: The impact of Ebola and related fears on facility-based child deliveries
The first known household survey examining the collateral harm to pregnancy services in areas affected by the West African Ebola epidemic suggests a significant slide backwards in child and maternal health. The study, conducted in Liberia, points to the deep disruptions caused by the Ebola epidemic -- even in parts of the country with relatively limited transmission.

Contact: Karen Teber
km463@gmail.com
Georgetown University Medical Center

Public Release: 1-Aug-2016
Journal of Antimicrobial Chemotherapy
New anti-HIV medication provides protection for women and infants
Each year, 1.5 million women living with HIV become pregnant. Without effective treatment, up to 45 percent of HIV-infected mothers will transmit the virus to their child, usually through breastfeeding. In an effort to prevent HIV transmission to women and their children, researchers from the University of North Carolina at Chapel Hill demonstrated the effectiveness of a new anti-HIV medication, EFdA, in pre-clinical animal models.
National Institutes of Health

Contact: Morag MacLachlan
morag_maclachlan@med.unc.edu
919-843-5719
University of North Carolina Health Care

Public Release: 1-Aug-2016
Journal of Experimental Medicine
New study finds CD4 T-Cell and Blimp-1 protein critical to toxoplasmosis regulation
Researchers from the George Washington University published in the Journal of Experimental Medicine finding a way to regulate chronic toxoplasmosis, one of the most common parasitic diseases worldwide. This research also has important implications for cancer.
National Institutes for Health

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University

Public Release: 1-Aug-2016
Applied and Environmental Microbiology
Green monkeys acquired Staphylococcus aureus from humans
Already it's known that many deadly diseases that afflict humans were originally acquired through contact with animals. However new research from the University of Warwick shows that pathogens can also jump the species barrier to move from humans to animals.

Contact: Nicola Jones
N.Jones.1@warwick.ac.uk
07-920-531-221
University of Warwick

Public Release: 1-Aug-2016
PLOS Pathogens
Griffith scientists unlock the 'Malaria box'
A 'Malaria Box' that could hold the answer to discovering new drugs to treat tropical diseases and cancer has been created for researchers around the world.

Contact: Stephanie Bedo
s.bedo@griffith.edu.au
040-872-7734
Griffith University

Public Release: 29-Jul-2016
Cell Reports
Zika infection is caused by one virus serotype, NIH study finds
Vaccination against a single strain of Zika virus should be sufficient to protect against genetically diverse strains of the virus, according to a study conducted by investigators from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health; Washington University in St. Louis; and Emory University in Atlanta.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
jennifer.routh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 29-Jul-2016
Science Immunology
Tracking how HIV disrupts immune system informs vaccine development
One of the main mysteries confounding development of an HIV vaccine is why some people infected with the virus make the desired antibodies after several years, but a vaccine can't seem to induce the same response.
NIH/National Institute of Allergy and Infectious Diseases, Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery, MRC Programme Grant

Contact: Samiha Khanna
samiha.khanna@duke.edu
919-419-5069
Duke University Medical Center

Public Release: 28-Jul-2016
PLOS Pathogens
INRS professor's team unveils new Leishmania virulence strategies
Professor Albert Descoteaux of INRS-Institut Armand-Frappier Research Centre and his team have discovered novel virulence strategies employed by the Leishmania parasite. These scientific breakthroughs recently published in the prestigious PLOS Pathogens journal represent two important clues to understanding the cellular and molecular mechanisms governing the parasitic infections that cause leishmaniasis, a neglected tropical disease endemic in one hundred countries.
Canadian Institutes of Health Research, Medical Research Council, Centre for Host-Parasite Interactions

Contact: Gisèle Bolduc
gisele.bolduc@adm.inrs.ca
418-654-2501
Institut national de la recherche scientifique - INRS

Public Release: 28-Jul-2016
Thorax
Introduction of screening could significantly reduce lung cancer deaths
The introduction of lung cancer screening in the UK could significantly reduce deaths in high risk groups, without causing participants the undue stress sometimes associated with medical tests.

Contact: Julia Short
ShortJ4@cardiff.ac.uk
44-029-208-75596
Cardiff University

Public Release: 28-Jul-2016
PLOS Pathogens
Open-source drug discovery a success
In what is being called the first-ever test of open-source drug-discovery, researchers from around the world have successfully identified compounds to pursue in treating and preventing parasite-borne illnesses such as malaria as well as cancer. The results have ignited more a dozen drug-development projects for a variety of diseases.
Medicines for Malaria Venture

Contact: Bobbi Nodell
bnodell@uw.edu
206-543-7129
University of Washington Health Sciences/UW Medicine

Public Release: 28-Jul-2016
PLOS Pathogens
Toward an effective TB vaccine: Analysis of the immune response to a promising candidate
BCG, the only currently approved TB vaccine, is only partially effective. Given the complicated TB treatment, the rise of adult TB cases in conjunction with the HIV epidemic, and increasing multidrug-resistant TB strains, a new and better vaccine is a global health priority. A study published on July 28 in PLOS Pathogens dissects the immune response in mice to an experimental vaccine and shows why it is highly effective.

Contact: Laleh Majlessi
laleh.majlessi@pasteur.fr
PLOS

Public Release: 27-Jul-2016
Neuropsychiatric Disease and Treatment
Zika virus challenges for neuropsychiatry recently published by Dove Medical Press
The Zika virus led the World Health Organization to declare the outbreak a global public health emergency in February 2016, but how much is really known about its neurobiology and potential neuropsychiatric manifestations?

Contact: Angela Jones
angela@dovepress.com
Dove Medical Press

Public Release: 27-Jul-2016
Cell
Studies in mice provide insights into antibody-Zika virus interactions
In research that could inform prophylactic treatment approaches for pregnant women at risk of Zika virus infection, investigators conducted experiments in mice and identified six Zika virus antibodies, including four that neutralize African, Asian and American strains of the mosquito-borne virus. The NIAID-supported team also developed atomic-level X-ray crystal structure images showing four of the antibodies in complex with three distinct regions (epitopes) of a key Zika protein.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 27-Jul-2016
The Lancet
Physical inactivity cost the world $67 billion in 2013 says first ever estimate
A world-first study has revealed that in 2013, physical inactivity cost $67.5 billion globally in health-care expenditure and lost productivity, revealing the enormous economic burden of an increasingly sedentary world. The study, published today in The Lancet, was led by Dr. Melody Ding from University of Sydney, leader of the current Lancet physical activity series.

Contact: Kobi Print
kobi.print@sydney.edu.au
61-481-012-729
University of Sydney

Public Release: 26-Jul-2016
Vector-Borne and Zoonotic Diseases
Could the deadly mosquito-borne yellow fever virus cause a Zika-like epidemic in the Americas?
Yellow fever virus (YFV), a close relative of Zika virus and transmitted by the same type of mosquito, is the cause of an often-fatal viral hemorrhagic fever and could spread via air travel from endemic areas in Africa to cause international epidemics.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 26-Jul-2016
Protein & Cell
Cracking the mystery of Zika virus replication
Zika virus has become a household word. It can cause microcephaly, a birth defect where a baby's head is smaller than usual. Additionally, it is associated with Guillain-Barré syndrome, a neurological disorder that could lead to paralysis and even death. However, how this microbe replicates in the infected cells remains a mystery. Now, an international team has unraveled the puzzle of how Zika virus replicates and published their finding in Springer's journal Protein & Cell.
National Basic Research Program of China, National Natural Science Foundation of China

Contact: June Tang
june.tang@springer.com
86-108-267-0211
Springer

Public Release: 26-Jul-2016
European Journal of Preventive Cardiology
Low physical capacity second only to smoking as highest death risk
A 45 year study in middle-aged men has shown that the impact of low physical capacity on risk of death is second only to smoking. The research is published today in the European Journal of Preventive Cardiology.
Förenade Liv

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 25-Jul-2016
Best-selling lipid for skin and hair also holds promise for Alzheimer's
The best-selling lipid in the world, often prominently featured on skin cream and shampoo labels, appears to also hold promise for Alzheimer's treatment, scientists say.
National Institutes of Health

Contact: Toni Baker
tbaker@augusta.edu
706-721-4421
Medical College of Georgia at Augusta University

Public Release: 25-Jul-2016
Journal of Allergy and Clinical Immunology
Hot desert storms increase risk of bacterial meningitis in Africa
Exposure to airborne dust and high temperatures are significant risk factors for bacterial meningitis, a new study by the University of Liverpool has found.

Contact: Nicola Frost
nicola.frost@liverpool.ac.uk
University of Liverpool

Public Release: 25-Jul-2016
Nature Structural & Molecular Biology
Researchers 'solve' key Zika virus protein structure
Researchers have revealed the molecular structure of a protein produced by the Zika virus that is thought to be involved in the virus's reproduction and its interaction with a host's immune system.

Contact: Jim Erickson
ericksn@umich.edu
734-647-1842
University of Michigan

Public Release: 25-Jul-2016
Annals of Internal Medicine
Low Zika risk for travelers to Olympics in Brazil, study finds
The Zika virus poses a negligible health threat to the international community during the summer Olympic Games that begin next month in Rio de Janeiro, Brazil, according to researchers at Yale School of Public Health.

Contact: Michael Greenwood
michael.greenwood@yale.edu
203-737-5151
Yale University

Public Release: 25-Jul-2016
Nature Genetics
Newly found, 'thrifty' genetic variant influences Samoan obesity
A new study reports that a genetic variant that affects energy metabolism and fat storage partly explains why Samoans have among the world's highest levels of obesity.
National Institutes of Health, Brown University

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 24-Jul-2016
PLOS Pathogens
ANU scientists exploit malaria's Achilles' heel
Malaria researchers at the Australian National University have found one of the malaria parasite's best weapons against drug treatments turns out to be an Achilles' heel, which could be exploited to cure the deadly disease.
National Health and Medical Research Council

Contact: Dr. Rowena Martin
rowena.martin@anu.edu.au
61-261-970-051
Australian National University

Showing releases 526-550 out of 1333.

<< < 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 > >>